<?xml version="1.0" encoding="UTF-8"?><MedicinalProduct xmlns="http://hl7.org/fhir"><id value="MedicinalProduct-example"/><meta><versionId value="22"/><lastUpdated value="2022-02-18T00:39:37.581+08:00"/></meta><identifier><system value="http://ema.europa.eu/example/MPID"/><value value="89yQuncxc4"/></identifier><productClassification><coding><system value="http://ema.europa.eu/example/WHOAnatomicalTherapeuticChemicalATCClassificationSystem"/><code value="WHOAnatomicalTherapeuticChemicalATCClassificationSystem|B01AF02"/></coding></productClassification><attachedDocument><reference value="DocumentReference/example"/></attachedDocument><masterFile><reference value="DocumentReference/example"/></masterFile><name><productName value="Equilidem 2.5 mg film-coated tablets"/><namePart><part value="Equilidem"/><type><code value="INV"/></type></namePart><namePart><part value="2.5 mg"/><type><code value="STR"/></type></namePart><namePart><part value="film-coated tablets"/><type><code value="FRM"/></type></namePart><countryLanguage><country><coding><system value="http://ema.europa.eu/example/countryCode"/><code value="EU"/></coding></country><jurisdiction><coding><system value="http://ema.europa.eu/example/jurisdictionCode"/><code value="EU"/></coding></jurisdiction><language><coding><system value="http://ema.europa.eu/example/languageCode"/><code value="EN"/></coding></language></countryLanguage></name><manufacturingBusinessOperation><operationType><coding><system value="http://ema.europa.eu/example/manufacturingOperationType"/><code value="Batchrelease"/></coding></operationType><authorisationReferenceNumber><system value="http://ema.europa.eu/example/manufacturingAuthorisationReferenceNumber"/><value value="o1Xxl76YgpaDdL"/></authorisationReferenceNumber><effectiveDate value="2013-03-15T08:00:00+08:00"/><manufacturer><reference value="Organization/example"/></manufacturer><regulator><reference value="Organization/example"/></regulator></manufacturingBusinessOperation></MedicinalProduct>